Ganoderma lingzhi (Red Reishi)
A species formally split off in 2012 from the Ganoderma lucidum complex — it, not the European reishi, is what's actually behind most Asian products sold as 'reishi' or 'lingzhi,' including the 'Red Reishi' label.
Number of studies
2
Safety
Requires caution
Time to effects
Subjective effects are sometimes reported after 2–4 weeks; changes in immune parameters have been observed after 8–12 weeks.
Monthly cost
ok. 40–90 zł/miesiąc
Price in Poland
40–90 zł za 90–100 kapsułek ekstraktu owocnika lub 35–60 zł za 100 g proszku
Who it's for
Ceny praktycznie pokrywają się z produktami sprzedawanymi jako zwykłe 'reishi' — to w większości ten sam surowiec pod inną nazwą handlową.
Indicative prices for the Polish market — we don't point to specific retailers; the real price depends on the manufacturer, form and place of purchase.
Table of contents
TL;DR
A species formally split off in 2012 from the Ganoderma lucidum complex — it, not the European reishi, is what's actually behind most Asian products sold as 'reishi' or 'lingzhi,' including the 'Red Reishi' label.
- →Immunomodulation described in studies of 'reishi' — the research material today mostly corresponds taxonomically to G. lingzhi
- →Higher documented triterpenic acid content than authentic European G. lucidum
- →Traditional use in Chinese and Japanese medicine identical to that of classic reishi
| Latin name | Ganoderma lingzhi Y. Cao, J.W. Wu & Y.C. Dai |
|---|---|
| Family | Ganodermataceae |
| Active substances | Beta-glucans, ganoderic acids (lanostane triterpenes) |
| Form | Fruiting-body extract (capsules, powder) |
| Evidence level | Preliminary — most evidence predates the formal species split (2012) |
| Interactions | Anticoagulant/antiplatelet drugs, immunosuppressants, blood-pressure-lowering drugs |
| Status | Dietary supplement sold under the name 'reishi'/'lingzhi'/'Red Reishi' |
Understand
Overview
Ganoderma lingzhi is a reddish-brown, lacquered-looking mushroom that was described for decades simply as Ganoderma lucidum — until 2012, when the team of Cao, Wu and Dai formally split it off as a distinct species based on molecular analysis. The true, European Ganoderma lucidum sensu stricto is a different thing from the mushroom cultivated at scale in China, Japan, Korea and Taiwan — the latter is mostly Ganoderma lingzhi.
This has a practical implication for consumers: a DNA analysis of 20 commercial 'reishi' products (Loyd et al., 2018) found that 93% contained material genetically corresponding to G. lingzhi, and none contained true European G. lucidum. This entry doesn't describe a 'new, better' mushroom — it explains what the product most often reaching consumers under the name reishi/lingzhi/Red Reishi actually is.
Who might this help? Mainly people who buy products labeled 'reishi,' 'lingzhi,' or 'Red Reishi' anyway and want to know that in practice they're getting the same raw material under a different name — there's no point paying extra for 'Red Reishi' as a supposedly more potent variant. The realistic effect is, at most, mild, long-term immune support, not something stronger than ordinary reishi. People with liver disease, clotting disorders, or who are pregnant or breastfeeding should exercise exactly the same caution as with the classic reishi mushroom.
Where it's found
Found mainly in China, Japan, Korea and Taiwan, where it's cultivated at scale on sawdust substrate or hardwood logs. It doesn't occur naturally in Europe — it's precisely this species that dominates global commercial cultivation.
Mechanism of action
The profile of active compounds is analogous to what's described for classic reishi: polysaccharides with immunomodulatory action and triterpenes with anti-inflammatory action. Chemical analysis showed that extracts from authentic European G. lucidum contain markedly fewer triterpenic acids than extracts from G. lingzhi. Because most of the clinical studies cited as evidence for the effects of 'reishi' were conducted on Asian material predating 2012, it isn't practically possible to separate out a distinct evidence base for the two species.
Beta-glucan polysaccharides bind to pattern-recognition receptors (including Dectin-1) on the surface of macrophages and NK cells, triggering an immunomodulatory response cascade. Key caveat: because the species split only occurred in 2012, none of these mechanisms has been formally verified separately for G. lingzhi versus G. lucidum sensu stricto.
Binding of beta-glucans to innate immunity receptors
Polysaccharides from the fungal cell wall bind to Dectin-1-type receptors on the surface of macrophages and NK cells.
Activation of the immunomodulatory response
Stimulated immune cells release cytokines that regulate the inflammatory response.
Inhibition of inflammatory pathways by triterpenes
Ganoderic acids, present at higher concentrations than in European G. lucidum, modulate inflammatory pathways in in vitro studies.
Taxonomic limitation of the evidence
Because the species were only split in 2012, none of the above mechanisms has been formally verified separately for G. lingzhi.
Evidence: early-stage — based on 2 studies in this database.
Benefits
Common myths
MythRed Reishi (Ganoderma lingzhi) is a different, more potent species than ordinary reishi.
FactIn most cases it's exactly the same plant material — an analysis of 20 commercial products found that 93% contained G. lingzhi, and none contained true European G. lucidum.
Forms & variants
Ganoderma lingzhi (Red Reishi) comes in several forms that differ in bioavailability and use case — the form you pick genuinely matters for how effective the supplementation is.
Fruiting-body extract in capsules ('Reishi' or 'Lingzhi')
In the vast majority of cases this is G. lingzhi material, regardless of the name on the label.
Best for: People wanting a convenient dose
Products marketed as 'Red Reishi'
The name refers to the color of the fruiting body, not a distinct, 'more potent' species.
Best for: People wanting to distinguish color marketing from a genuine species difference
Practice
Frequently asked questions
Until 2012 they were treated as the same species. However, molecular analysis showed that the material sold today as 'reishi' is most often taxonomically G. lingzhi, not true European G. lucidum.
Dosage & timing
Typical dose
1000–3000 mg of fruiting-body extract daily — a range identical to that used in studies on 'reishi/lingzhi' in general
Form
Fruiting-body extract standardized to beta-glucans and triterpenes
Because the product bought as 'reishi' and as 'lingzhi'/'Red Reishi' is in practice most often the same species, dosing and safety guidance should be treated the same as in the entry on classic reishi.
Best times to take it
- With a meal containing fat
- In the evening, if the goal is to support relaxation and sleep
What to combine with
Good combinations
Lion's Mane — A common combination in mushroom 'stacks'
Cordyceps militaris — A popular pairing in multi-ingredient supplements
Use caution with
Reishi (Ganoderma lucidum) — In practice this is most often the same profile of active compounds sold under a different brand name — combining both products usually just means doubling the dose with no added benefit
Safety
Side effects & contraindications
Possible side effects
Gastrointestinal discomfort at high doses — same as classic reishi
Isolated case reports of hepatotoxicity with prolonged, high-dose use
Contraindications
Liver disease — caution
Clotting disorders and planned surgery
Pregnancy and breastfeeding
Mushroom allergy
Interactions
Anticoagulant/antiplatelet drugs
Immunosuppressive drugs
Blood-pressure-lowering drugs
Is it worth taking?
Who it's for
- People considering reishi/lingzhi supplementation who want to understand which species they're actually buying
- People looking for mild, long-term immune support
Not for
- Liver disease — caution
- Clotting disorders and planned surgery
- Pregnancy and breastfeeding
- Mushroom allergy
Evidence
Worth knowing
In 2012, Cao, Wu and Dai formally split Ganoderma lingzhi off from the Ganoderma lucidum complex.
A DNA analysis of commercial 'reishi' products found not a single product containing true European G. lucidum sensu stricto.
Studies
A DNA analysis of 20 commercial products marketed as Ganoderma lucidum found that 93% contained material genetically corresponding to G. lingzhi — and none contained true European G. lucidum.
Loyd et al., Frontiers in Microbiology, 2018
Species clarification of the prize medicinal Ganoderma mushroom 'Lingzhi'
Strong evidenceCao Y, Wu SH, Dai YC · Fungal Diversity · 2012
The paper that formally split Ganoderma lingzhi off as a species distinct from Ganoderma lucidum based on phylogenetic analysis of ITS sequences.
View studyIdentifying the 'Mushroom of Immortality': Assessing the Ganoderma Species Composition in Commercial Reishi Products
Strong evidenceLoyd AL, Richter BS, Jusino MA, Truong C, Smith ME, Blanchette RA, Smith JA · Frontiers in Microbiology · 2018
A DNA analysis of 20 commercial products marketed as Ganoderma lucidum found that 93% contained material genetically corresponding to G. lingzhi, and none contained true European G. lucidum.
View studySources & bibliography
Citations are illustrative for this demo version and require full bibliographic verification by the editorial team before production publication.
Compare with similar entries
About the authors of this entry
Author
Julia WiśniewskaEditor, Neurohacking & Sleep
Julia writes about nootropics, chronobiology and recovery protocols.
45 publications on this site
Medical review
dr Piotr ZielińskiEndocrinologist
Piotr reviews content on hormones, metabolic health and supplement pharmacology.
131 publications on this site
Related entries
4.2Reishi (Ganoderma lucidum)
A functional mushroom with more than 2,000 years of history in Chinese and Japanese medicine, studied for its immune-modulating effects — human clinical evidence, however, remains modest and partly contradictory.
3.8Ganoderma sinense (Black Reishi)
A rare, dark-purple bracket fungus known in Chinese medicine as 'Zi Zhi' — unlike Ganoderma lingzhi, this is a genetically distinct species, with its own, smaller body of research: a chemotherapy-support drug registered in China, plus preliminary data on protecting the heart from anthracycline cardiotoxicity.
4.4Lion's Mane
A functional mushroom studied for its effect on nerve growth factor (NGF) and cognitive function — human evidence is still preliminary.
4.1Cordyceps militaris
A laboratory-cultivated functional mushroom — this is the species behind almost every 'cordyceps' supplement sold today. High, stable cordycepin content, but evidence for improved physical performance in humans is still mixed.
4.5Turkey Tail
The mushroom behind PSK and PSP — the only fungal polysaccharides registered in Japan as drugs supporting chemotherapy. Among the most solid clinical evidence of any functional mushroom, but this is NOT a standalone cancer therapy.
4.3Shiitake
A culinary-functional mushroom rich in lentinan and beta-glucans, studied clinically for immune modulation and lipid profile — one of the best-researched functional mushrooms on the market.
4.3Oyster Mushroom (Pleurotus ostreatus)
One of the most popular edible mushrooms in Poland, containing a natural compound structurally similar to lovastatin — studied mainly for its effects on lipid profile and immunity.
4.1Almond Mushroom (Agaricus blazei)
A mushroom from the Brazilian forests studied mainly for immune modulation and blood-sugar support — human evidence is mixed and preliminary, despite the supplement's considerable popularity.
Related articles
Opinie ekspertówFunctional Mushroom Ranking: Which Ones Have the Strongest Scientific Evidence
Reishi, shiitake, lion's mane, cordyceps, chaga... The VitMode knowledge base covers more than 50 species of medicinal mushrooms. We picked the five with the most solid evidence base and ranked them by specific use case.
August 18, 2026
PoradnikiCold Showers and Immunity: Do You Really Get Sick Less?
"Cold exposure boosts your immune system" is one of the most repeated claims in biohacking — but the newest, largest meta-analysis on the topic shows something more complex: inflammation rises short-term, and immune markers don't budge. There is, though, one real, if surprising, long-term effect. We break down the evidence.
August 22, 2026
PoradnikiZinc and the Common Cold: Does It Really Shorten It?
"Zinc shortens colds" is one of the oldest claims in supplementation — and one of the few backed by meta-analyses with concrete numbers. But this story has an instructive plot twist: part of the key Cochrane evidence was withdrawn over data errors. We break down the topic, including what you shouldn't trust uncritically.
August 22, 2026
PoradnikiVitamin C and the Common Cold: Does the Pauling Myth Hold Up?
Two-time Nobel laureate Linus Pauling argued in the 1970s that megadoses of vitamin C could prevent the common cold — a belief that still drives supplement sales worldwide today. The largest Cochrane review, covering over 11,000 participants, tells a far more nuanced story: for the average person, regular vitamin C supplementation barely moves the needle on catching a cold. But there's a clear exception — and the data behind it is some of the strongest in the entire review.
August 23, 2026
Comments (2)
- KW
Kasia W. 2 weeks ago
Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.
- MT
Marek T. a month ago
Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.